Drug Type ASO |
Synonyms |
Target |
Action inhibitors |
Mechanism CD74 inhibitors(HLA-DR antigens-associated invariant chain inhibitors), MIF inhibitors(Macrophage migration inhibitory factor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cachexia | Preclinical | South Korea | 30 Sep 2024 |